RxDoctor Payments Data

Kelli Karper

Family Medicine · Pineville, WVNPI 1760573067

Payments from drug & device makers

$2,805in general payments, 2019–2025

Across 151 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$915
  • AbbVie$430
  • Novo Nordisk$338
  • GSK$284
  • Pfizer$273
  • Lilly USA, LLC$156
  • plus $409 from 9 others

What the payments were for

  • Food & beverage$2,805100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,805 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide96$100,540
EliquisApixaban84$69,424
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$46,617
OzempicSemaglutide39$39,747
FarxigaDapagliflozin Propanediol39$39,365
JanuviaSitagliptin Phosphate43$37,253
LinzessLinaclotide27$19,478
Tresiba Flextouch U-200Insulin Degludec24$16,508
JardianceEmpagliflozin22$13,531
Repatha SureclickEvolocumab22$13,094
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,771
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$8,600
MyrbetriqMirabegron11$8,171
VascepaIcosapent Ethyl15$7,866
Repatha SyringeEvolocumab19$7,386

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$156$100,54096 claims
PfizerEliquis, Premarin, Paxlovid$273$78,119114 claims
AstraZenecaFarxiga, Breztri Aerosphere$915$51,13658 claims
GSKTrelegy Ellipta$284$46,61748 claims
Novo NordiskOzempic$338$39,74739 claims
AbbVieLinzess, Synthroid$430$21,58568 claims
Boehringer IngelheimJardiance$19$13,53122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Pineville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →